Bakiki, Cherry Mae .
HRN: 25-26-24 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/29/2024
AZITHROMYCIN 500MG TABLET (TAB)
07/29/2024
08/02/2024
PO
500mg
Q24
CAPMR
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes